Khosla Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Emergent announces a £50m Series B led by Khosla Ventures and SoftBank for its AI app development platform
Emergent offers an AI-powered app development platform that lets users design, build and monetise production-ready software without traditional engineering teams or large development budgets.
PolyAI raises £64m Series D co-led by Georgian, Hedosophia and Khosla Ventures to power enterprise conversational AI
PolyAI develops conversational AI agents for large enterprises, enabling natural voice interactions at scale across customer service operations in sectors including finance, healthcare and hospitality.
Mimica raises £20m Series B led by Paladin Capital Group to capture, map and optimise business processes with AI
Mimica captures how work is actually done inside organisations, turning everyday processes into structured data that can be used to train reliable AI automation.
Omnea raises £37m Series B led by Insight Partners and Khosla Ventures to build intelligent procurement orchestration platform
Omnea develops AI-powered procurement software that acts as a single intake and orchestration layer, helping organisations manage supplier requests, workflows and risk across finance, legal and operations teams.
Charm Therapeutics raises £60m Series B led by NEA and SR One to advance next generation cancer drug
Charm Therapeutics develops next generation cancer drugs designed to overcome treatment resistance, using an AI driven discovery platform to identify compounds for aggressive blood cancers such as AML.
Recraft raises £22.5m Series B led by Accel to deliver brand-consistent generative AI design at scale
Recraft builds a generative AI design platform that allows creative teams to produce images with consistent brand styles, offering precise control over layout, text and visual elements at scale.
C the Signs announces £6m investment from Khosla Ventures to advance AI-powered early cancer detection
C the Signs uses explainable AI to identify patients at risk of cancer using existing health records, helping clinicians detect disease earlier and improve survival outcomes.
Genie AI raises £13m led by GV to reduce legal friction and boost economic efficiency
Genie AI builds an AI legal editor that helps teams draft, review and assess contracts quickly, combining personalised drafting with risk analysis across multiple jurisdictions.
More venture news
- 29 Jul 2026
GreyparrotGreyparrot raises £20m Series B from angels for AI camera systems that read waste on recycling belts
Series BClimate - 29 Jul 2026
QureightQureight lands £15m Series B led by Molten Ventures to bring AI imaging to clinical trials for lung and heart disease
Series BLife Sciences - 28 Jul 2026
Dwelly lands £130m in funding led by EQT Growth and General Catalyst to acquire and run independent lettings agencies on shared AI infra
Series BProperty
